Biotech Pro ApS Financials, key figures and credit report
Gross profit 57.2 kDKK FY 2024 +462.2% vs 2023
EBIT 57.2 kDKK FY 2024 +462.2% vs 2023
Net debt - 877.6 kDKK FY 2024 +0.8% vs 2023
Quick ratio 1.6 FY 2024 +0.1 vs 2023
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 84.83 | 169.38 | 89.30 | -15.80 | 57.23 |
| EBIT | 84.83 | 169.38 | 89.30 | -15.80 | 57.23 |
| Other financial income | 0.01 | 0.22 | 0.05 | ||
| Other financial expenses | -2.99 | -3.96 | -3.54 | -3.64 | -2.85 |
| Reduction non-current investment assets | -0.00 | -13.33 | |||
| Net income from associates (fin.) | -0.00 | ||||
| Pre-tax profit | 81.85 | 152.09 | 85.77 | -19.22 | 54.42 |
| Income taxes | -16.90 | -23.25 | -19.02 | -0.02 | -8.14 |
| Net earnings | 64.96 | 128.83 | 66.75 | -19.24 | 46.28 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 0.00 | ||||
| Investments total | 0.00 | ||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 13.64 | 6.91 | 14.95 | 7.93 | 6.96 |
| Current deferred tax assets | 8.01 | 3.22 | 6.26 | ||
| Short term receivables total | 21.65 | 6.91 | 14.95 | 11.15 | 13.23 |
| Cash and bank deposits | 247.45 | 294.37 | 940.06 | 900.41 | 896.30 |
| Cash and cash equivalents | 247.45 | 294.37 | 940.06 | 900.41 | 896.30 |
| Balance sheet total (assets) | 269.10 | 301.28 | 955.01 | 911.56 | 909.52 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -0.70 | 64.26 | 193.09 | 259.84 | 240.60 |
| Profit of the financial year | 64.96 | 128.83 | 66.75 | -19.24 | 46.28 |
| Shareholders equity total | 114.25 | 243.09 | 309.84 | 290.60 | 336.88 |
| Non-current deferred tax liabilities | 15.46 | 21.00 | 18.76 | 4.15 | |
| Non-current liabilities total | 15.46 | 21.00 | 18.76 | 4.15 | |
| Current trade creditors | 116.57 | 10.00 | 12.83 | 5.50 | 5.50 |
| Current owed to participating | 13.20 | 13.73 | 14.77 | 15.51 | 18.69 |
| Current owed to group member | 9.61 | ||||
| Short-term deferred tax liabilities | 13.46 | 18.00 | 19.14 | ||
| Other non-interest bearing current liabilities | 0.01 | 0.00 | 0.53 | ||
| Accruals and deferred income | 580.81 | 580.81 | 543.77 | ||
| Current liabilities total | 139.38 | 37.19 | 626.42 | 620.96 | 568.49 |
| Balance sheet total (liabilities) | 269.10 | 301.28 | 955.01 | 911.56 | 909.52 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated